SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Zevra Therapeutics Q3 Results Scheduled for November 3

Zevra Therapeutics is scheduled to report Q3'26 results on November 3 after market close.

ZVRA

Related stories